SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (A) (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL ®, a recently approved CAR ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc (NYSE: A) today announced the release of a new 21 CFR Part 11 compliance software for the Agilent xCELLigence Real-Time Cell Analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback